Sanara MedTech Reports 8% Revenue Growth and $5.6 Million Adjusted EBITDA

Sanara MedTech reported third-quarter 2026 revenue of $28.4 million, up 8% year over year, and net income from continuing operations was a loss of $1.3 million. Gross margin was 93%, while Adjusted EBITDA increased to $5.6 million. The company lowered its full-year revenue guidance to $110 million…